TITLE

Weight change and its impact on prognosis after adjuvant TAC (docetaxel-doxorubicin-cyclophosphamide) chemotherapy in Korean women with node-positive breast cancer

AUTHOR(S)
Jeon, Ye; Lim, Seung; Choi, Hyun; Suh, Young
PUB. DATE
March 2014
SOURCE
Medical Oncology;Mar2014, Vol. 31 Issue 3, p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
94629110

 

Related Articles

  • RESPONSE. Ragaz, Joseph; Olivotto, Ivo A.; Wilson, Kenneth S.; Spinelli, John J.; Durand, Ralph // JNCI: Journal of the National Cancer Institute;8/3/2005, Vol. 97 Issue 15, p1163 

    Presents a response by J. Ragaz and colleagues to a letter to the editor about their article "Adjuvant Radiotherapy and Chemotherapy in Node-Positive Premenopausal Women With Breast Cancer".

  • Adjuvant Docetaxel for Node-Positive Breast Cancer. Martin, Miguel; Pienkowski, Tadeusz; Mackey, John; Pawlicki, Marek; Guastalla, Jean-Paul; Weaver, Charles; Tomiak, Eva; Al-Tweigeri, Taher; Chap, Linnea; Juhos, Eva; Guevin, Raymond; Howell, Anthony; Fornander, Tommy; Vogel, Charles; Coleman, Robert; Vinholes, Jeferson; Modiano, Manuel; Pinter, Tamas; Tang, Shou C.; Colwell, Bruce // New England Journal of Medicine;6/2/2005, Vol. 352 Issue 22, p2302 

    Background: We compared docetaxel plus doxorubicin and cyclophosphamide (TAC) with fluorouracil plus doxorubicin and cyclophosphamide (FAC) as adjuvant chemotherapy for operable node-positive breast cancer. Methods: We randomly assigned 1491 women with axillary node-positive breast cancer to six...

  • Weight gain after adjuvant chemotherapy in patients with early breast cancer in Istanbul Turkey. Basaran, Gul; Turhal, Nazim Serdar; Cabuk, Devrim; Yurt, Nevin; Yurtseven, Gul; Gumus, Mahmut; Teomete, Mehmet; Dane, Faysal; Yumuk, Perran Fulden // Medical Oncology;Jun2011, Vol. 28 Issue 2, p409 

    Weight gain is a well-known and unwanted complication of adjuvant chemotherapy in breast cancer. We observed that the female Turkish cancer patients frequently gain weight with adjuvant treatment of breast cancer and planned to examine the magnitude of this problem in early breast cancer...

  • Obesity as an Adverse Prognostic Factor for Patients Receiving Adjuvant Chemotherapy for Breast Cancer. Bastarrachea, Jorge; Hortobagyi, Gabriel N.; Smith, Terry L.; Kau, Shu-Wan C.; Buzdar, Aman U. // Annals of Internal Medicine;1/1/94, Vol. 120 Issue 1, p18 

    Objective: To determine whether obesity is an independent prognostic factor among women receiving adjuvant chemotherapy for lymph node-positive breast cancer and to determine how obesity relates to other commonly used prognostic indicators. Design: Retrospective review of the clinical...

  • Treatment -- Adjuvant and Neoadjuvant Therapy.  // Current Medical Literature: Breast Cancer;2006, Vol. 18 Issue 3, p83 

    The article provides an overview of citations about adjuvant and neoadjuvant cancer therapy. They include "Tamoxifen and Contralateral Breast Cancer in BRCA1 and BRCA2 Carriers: An Update," by J. Gronwald et al, "Tamoxifen After Adjuvant Chemotherapy for Premenopausal Women With Lymph...

  • Re: Locoregional Radiation Therapy in Patients With High-Risk Breast Cancer Receiving Adjuvant Chemotherapy: 20 Year Results of the British Columbia Randomized Trial. Kunkler, Ian // JNCI: Journal of the National Cancer Institute;8/3/2005, Vol. 97 Issue 15, p1162 

    Presents a letter to the editor commenting on J. Ragaz and colleagues' article titled "Adjuvant Radiotherapy and Chemotherapy in Node-Positive Premenopausal Women With Breast Cancer". Presents a letter

  • Effectiveness of Adjuvant Chemotherapy for Node-Positive Operable Breast Cancer in Older Women. Du, Xianglin L.; Jones, Dennie V.; Dong Zhang; Morley, John E. // Journals of Gerontology Series A: Biological Sciences & Medical ;Sep2005, Vol. 60 Issue 9, p1137 

    Background. Randomized clinical trials have shown the efficacy of adjuvant chemotherapy in treating node-positive operable breast cancer in women aged ≤69 years, but the benefit of chemotherapy in women aged ≥70 is questionable. This study was to examine if adjuvant chemotherapy is...

  • Adjuvant chemotherapy may contribute to an increased risk for metabolic syndrome in patients with breast cancer. Bicakli, Derya Hopanci; Varol, Umut; Degirmenci, Mustafa; Tunali, Didem; Cakar, Burcu; Durusoy, Raika; Karaca, Burcak; Ali Sanli, Ulus; Uslu, Ruchan // Journal of Oncology Pharmacy Practice;Feb2016, Vol. 22 Issue 1, p46 

    Purpose Cytotoxic treatment may cause weight gain and important alterations in the metabolic status of breast cancer (BC) patients. The aim of this study was to investigate the changes in metabolic and anthropometric parameters of patients with BC who received adjuvant chemotherapy. Methods All...

  • The effects of short-term fasting on tolerance to (neo) adjuvant chemotherapy in HER2-negative breast cancer patients: a randomized pilot study. de Groot, Stefanie; Vreeswijk, Maaike P. G.; Welters, Marij J. P.; Gravesteijn, Gido; Boei, Jan J. W. A.; Jochems, Anouk; Houtsma, Daniel; Putter, Hein; van der Hoeven, Jacobus J. M.; Nortier, Johan W. R.; Pijl, Hanno; Kroep, Judith R.; Vreeswijk, Maaike Pg; Welters, Marij Jp; Boei, Jan Jwa; van der Hoeven, Jacobus Jm; Nortier, Johan Wr // BMC Cancer;10/6/2015, Vol. 15 Issue 1, p1 

    Background: Preclinical evidence shows that short-term fasting (STF) protects healthy cells against side effects of chemotherapy and makes cancer cells more vulnerable to it. This pilot study examines the feasibility of STF and its effects on tolerance of chemotherapy in a...

  • 8. Adjuvant systemic therapy for women with node-positive breast cancer. OReilly, Susan E.; Allan, Sharon J.; Shenkier, Tamara N.; Gelmon, Karen A.; Levine, Mark N.; Olivotto, Ivo A.; Fields, Anthony L. A.; Bowman, David M.; Bouchard, Fran�oise; McGregor, Maurice // CMAJ: Canadian Medical Association Journal Supplement;2/10/1998 Breast Cancer, Vol. 158 Issue 3, pS52 

    Facilitates the choice of systemic adjuvant therapy for women with node-positive breast cancer. Evidence; Recommendations.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics